pain management. Pleurodynia
Conditions
Interventions
Intervention 1: We inject 0.25 mg/kg of ketamine and prepare a 5 cc syringe in 5 minutes infusion for the study patients. Intervention 2: We inject the dose of 30 mg of ketorolac and prepare a 5 cc sy
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age over 18 years 2. Patients with blunt and penetrating trauma, with a fracture of two ribs or more, or patients who need a chest tube insertion.
Exclusion criteria
Exclusion criteria: 1. People who have a history of allergies and drug reactions, especially to ketamine. 2. People with <= 13 GCS 3. People with acute coronary syndrome 4. Increase ICP 5. Severe hypertension (systolic pressure = and <from 180 mm Hg or diastolic = and <from 100 mm Hg) 6. People who are currently taking MAO inhibitors. 7. People with a history of psychosis 8. Consumers of psychiatric drugs (Pschycotropic) 9. Active dementia or delirium 10. Glaucoma 11. Pregnancy 12. Inability to express pain or communicate with people 13. Liver failure 14. Patients with active bleeding 15. Patients with gastric ulcer 16. Thrombocytopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of pain relief in response to ketamine. Timepoint: The basis of the amount of pain reported by the patient is measured at time zero (before drug injection), 5, 30 and then every 30 minutes to two hours. Method of measurement: Numerical Rating Scale(NRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHosein Zabihi
Tehran University of Medical Sciences
Outcome results
None listed